IBTROZI vs SPRYCEL

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. IBTROZI and SPRYCEL are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	IBTROZI	SPRYCEL
Rating	New	72/100
Pharmacy pays	—	~$839.19 /30
Type	RX	RX
Active ingredient	TALETRECTINIB ADIPATE	DASATINIB
Manufacturer	Nuvation	Bristol Myers Squibb
Dosage forms	Capsule	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma	Lymphoid Leukemia, Myeloid Leukemia

ibtrozi sprycel

Rating

New

72/100

Pharmacy pays

—

~$839.19 /30

Type

Active ingredient

TALETRECTINIB ADIPATE

DASATINIB

Manufacturer

Nuvation

Bristol Myers Squibb

Dosage forms

Capsule

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma

Lymphoid Leukemia, Myeloid Leukemia

Frequently asked questions

What is the difference between Ibtrozi and Sprycel?

Ibtrozi contains Taletrectinib Adipate, while Sprycel contains Dasatinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.